National Alliance of State Prostate Cancer Coalitions

Report from the 15th Annual Meeting and Gala

October 18, 2019 – October 20, 2019
Hotel Monaco, Washington, D.C.

“Educate, Participate, Celebrate”

The 15th Annual Meeting & Gala of the National Alliance of State Prostate Cancer Coalitions, also known as The Prostate Cancer Alliance, was held at the esteemed Hotel Monaco in Washington, D.C. on the site of the original General Post Office Building (circa 1840), from Friday, October 18, 2019 through 3:00 p.m. on Sunday, October 20, 2019.

This was a celebratory Annual Meeting, as it was a landmark year – our 15th year of helping prostate cancer patients and their families. State prostate cancer organizations – coalitions, foundations, associations and other entities - from across the entire United States, including Alaska and Hawaii, sent at least one, sometimes two or three representatives to the 15th Annual Meeting.

The expectation as always was that at the conclusion of the Annual Meeting, all attendees would return to their respective constituencies and then disseminate throughout their states, all of the educational, scientific and practical information they’d received, thereby helping patients everywhere. 

Annual Meeting Sponsors sent representatives to the 15th Annual Meeting & Gala to learn, to network and to work with state prostate cancer organizations, as well as to distribute their materials. There were a record 16 sponsors for this year’s event, and NASPCC is very grateful for their support which helped us to organize and hold this stellar Annual Meeting.

Save the Date

Save the date for NASPCC’s 16th Annual Meeting. The meeting will take place September 24-26, 2021 at the Hotel Monaco in Washington, DC. Please contact This email address is being protected from spambots. You need JavaScript enabled to view it.  for details.

15th Annual Meeting Proceedings

• Report from the 15th Annual Meeting (PDF)
• Conference Program (PDF)

Conference Presentation Files

All files are in PDF format that may require a plugin for viewing.

1a - Prostate Cancer: The Basics - Vincent P. Laudone, M.D.

1 - Arkansas Prostate Cancer Foundation Best Practices - Bev Eckert, Chris Collier

2 - From Academia to Community Care: Lessons Learned and Considerations for Delivering Excellent Care - Ashley E. Ross, M.D., Ph.D.

2a -Prostate Cancer Genetics 100 - Leonard G. Gomella, MD

3 -Prostate Cancer Treatment In A Community Setting - Gregory J Gagnon, M.D.

3a -Immunotherapy in Prostate Cancer - Adam R. Metwalli, MD

4 - Cancer Care - Dr. Goren

4a - Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent - Ashley E. Ross MD PhD

5 - Managing The Effects of Prostate Cancer Treatment - Krishnan Venkatesan

5a - ABCs of Androgen Deprivation Therapy (ADT) - Jeanny B. Aragon-Ching, M.D., F.A.C.P

6 - Prostate Cancer and African American Men - Judd W. Moul, M.D. FACS

7 - Prostate Cancer: Disease Localization and Risk Stratification - Vincent P. Laudone, M.D.

8 - Dawn of New Era for Prostate Cancer Patients - Asha Das, MD

9 - Prostate Cancer: Active Surveillance - Vincent P. Laudone, M.D.

10 - Low Risk Localized Prostate Cancer Panel: Genomic Tests - Judd W. Moul, M.D. FACS

11 - Focal therapy for prostate cancer - Daniel Song MD

12 - Multimodality Therapy for High Risk Disease – The Surgical Perspective - Vincent P. Laudone, M.D.

13 - Intermediate, High Risk and Oligometastatic Disease: Radiation Options - Dr Jeff Skinner

14 - Prostate Cancer and Non-Metastatic Castration-Resistant Prostate Cancer - Germino

15 - The Optimal Treatment of Bone Metastases - Philip Saylor, M.D.

16 - New and Developing Treatment Approaches for Patients with Non-Localized Prostate Cancer - Markowski

17 - PSA/Biochemical Recurrence of Prostate Cancer - Judd W. Moul, M.D., F.A.C.S.

18 - The Role of Nutrition and Lifestyle in Addressing Prostate Cancer - Joseph E. Scherger, MD, MPH

rev: 12/04/2020

Attachments:

Invitation15thMeetingGala.pdf	[Invitation to Gala Dinner and Meeting]	379 kB
Conference Program - PDF	[ ]	1047 kB

Here are some presentations from the NASPCC 14th Annual Meeting.

Use the links below to download the PowerPoint presentation slides for each presentation. Files in PDF are so indicated. A plugin or additional software is required to view this content.

1. The Importance of Hereditary Cancer Testing in Prostate Cancer - Rob Finch, MS, CGC
2. Genomics and Prostate Cancer - Cecilia Hammond, MSN
3. Genomic Testing: When and Why? - Rob Finch, MS, CGC
4. Why Nuclear AR-V7 - Katherine Atkinson
5. Active Surveillance for Low Risk Prostate Cancer - Michael A. Gorin, M.D.
6. THE DISEASE LANDSCAPE OF PROSTATE CANCER (PDF) - Nicholas Souders, Ph.D.
7. Chemotherapy Options for Advanced Prostate Cancer - Jeanny B. Aragon-Ching, M.D., F.A.C.P.
8. Bone Scan Index as a Prognostic Biomarker (PDF) - Karl Sjöstrand, PhD
9. 2018 UPDATE ON IMMUNOTHERAPY IN PROSTATE CANCER - James L. Gulley, M.D., Ph.D., F.A.C.P.
10. Radiation Therapy for Prostate Cancer - Ronald Chen, MD MPH
11. Patient-specific Treatment of Prostate Cancer - Shyam Natarajan, PhD
12. Space OAR Hydrogel - April Renzella
13. Positron Emission Tomography For Evaluation of Prostate Cancer - Eugene D Kwon MD
14. FDA Approvals for Systemic Treatment of Prostate Cancer in 2018 - William R Berry MD
15. ADVANCED PROSTATE CANCER: BONE ISSUES AND METASTASES - Samuel Denmeade, MD

Comments from Ms. Merel Nissenberg, President of the National Alliance of State Prostate Cancer Coalitions have appeared recently in several issues of Prostatepedia. 

Rivanna Health Publication's Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer each month tackling a different topic facing prostate cancer patients today.

Here are links to these recent articles:

How to Make Well-Informed Decisions When Dealing With Prostate Cancer

This recent article from Future of Personal Health, Ms. Nissenberg discusses resources from NASPCC and CPCC that help men 40 and older ask their doctor questions that will enable them to make informed decisions about whether to get tested for prostate cancer.

Use this link to read the entire article "How to Make Well-Informed Decisions When Dealing With Prostate Cancer"How to Make Well-Informed Decisions When Dealing With Prostate Cancer"

Helping Patients Navigate the World of Clinical Trials

In this May 2019 article, Ms. Nissenberg, along with Mr. Tom Kirk, who is the Vice-President of the California Prostate Cancer Coalition, discuss "how, why and when patients should consider a clinical trial.

Use this link to read the entire article "Helping Patients Navigate the World of Clinical Trials" - PDF

Merel Nissenberg: Focal Therapy on Prostate

In this April 2019 article, Ms. Nissenberg discusses the use of Focal Therapy as a treatment for Prostate Cancer. Interest in focal therapy is fueled by the promise of cancer control with fewer side effects than are seen after radiation or radical prostatectomy.

Use this link to read the entire article Focal Therapy on Prostate - PDF

Merel Nissenberg On Non-Metastatic Castrate-Resistant Prostate Cancer

In thie article, Ms. Nissenberg discussed non-metastatic, castrate-resistant prostate cancer (nmCRPC), a clinical state in which a patient on androgen-deprivation therapy (ADT) has a rising PSA but there are no radiological findings of metastases on CT or bone scan.

Use this link to read the entire article On Non-Metastatic Castrate-Resistant Prostate Cancer

Ms. Merel Nissenberg: Hypofractionated Radiotherapy

Ms. Merel Nissenberg is the President of the National Alliance of State Prostate Cancer Coalitions, a nation-wide organization comprised of state prostate cancer coalitions dedicated to saving men’s lives and enhancing the quality of life of prostate cancer patients and their families through awareness, education, and the development of a public policy network. In this article she offers two views of hypofractionated radiotherapy for prostate cancer.

Use this link to read the entire article Hypnofractionated Radiotherapy

Genetics Testing + Counseling

In the article, Ms. Nissenberg notes the National Alliance of State Prostate Cancer Coalitions strongly endorses the use of genetic testing and genetic counseling for prostate cancer, and urges clinicians to read, consider, and follow the scientifically sound suggestions of the 2017 Philadelphia Prostate Cancer Consensus Statement on the Role of Inherited Prostate Cancer Risk.

Use this link to read the entire article Genetics Testing + Counseling

Proceeding from the 13th Annual Meeting of NASPCC 

Use this link to read State Prostate Cancer Advocacy Groups Meet from January 2018

 rev: 06/28/2019

Attachments:

Focal Therapy on Prostate	[ ]	1499 kB
May 2019 Prostatepedia article	[ ]	143 kB